gwa wrote:If you read more about "The Myelin Repair Foundation", you will see that they are top notch MS researchers sharing their trials and experiments to bring more insight and hopefully decent meds within the next five years.
When this foundation was started, the main thrust was to get scientists to share and work together to hasten the discovery processes. According to their web site, many new discoveries have been made in the past year and half and they appear on target to help MS'ers in the near future.
Other groups of researchers are also working as a unit now too. I am just more familiar with the work being done at the MRF as I keep watching their site.
Maybe I would be a lot worse without them.
Oral Contraceptive Use in Patients with Multiple Sclerosis
Armando H. Sena, Rui G. Pedrosa, Lisboa, Portugal, Maria J. Cascais, Maria L. Andrade, Veronique M. Ferret-Sena, Maria G. Morais, Lisboa, Portugal, Remy Couderc, Paris, France
RESULTS: Before treatment, the Expanded Disability Status Scale (EDSS) was about 25% lower in OC users in comparison to never-users (2.201.31 vs 2.911.31; p= 0.028). A similar difference in EDSS scores was found between OC users and never-users after 12 months of IFN- therapy. This influence of OC use was not associated with the dose or form of IFN- , alterations of apoE levels or the apoE polymorphism. CONCLUSIONS/RELEVANCE: OC use may have a protective effect on the severity of MS and this influence is maintained in patients under IFN- treatment.
Users browsing this forum: No registered users